Gc Biopharma Corp
Clinical trials sponsored by Gc Biopharma Corp, explained in plain language.
-
Hunter syndrome drug hunterase passes Long-Term safety check in 30 patients
Disease control CompletedThis study looked at the long-term safety of Hunterase, a drug for Hunter syndrome, in 30 patients who had already completed a previous study or used the drug for over 6 months. The main goal was to check for side effects and changes in lab tests, physical exams, and heart activi…
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated May 26, 2026 11:41 UTC
-
New shot for hemophilia shows early promise in small study
Disease control CompletedThis early-stage study tested a new drug called MG1113 in 15 men with severe hemophilia A or B. The goal was to check if the drug is safe and how it works in the body. Participants received multiple doses under the skin. The study is complete, and results will help decide if larg…
Phase: PHASE1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated May 26, 2026 11:08 UTC